Clinical Trial Update: Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2) [Phase 4]

View source ↗

Summary

A Phase 4 trial ROTATE-2 investigating albuminuria targeting in diabetic nephropathy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Snippet

Sponsor: Steno Diabetes Center Copenhagen | Conditions: Diabetic Nephropathy Type 2 | Phase 4 | Status: WITHDRAWN